The impact of obstructive sleep apnea on high-sensitivity C-reactive protein in subjects with or without metabolic syndrome

Sleep and Breathing

Volumn 19, Issue 4, 2015, Pages 1449-1457

  Wu, Wei Te ^a   Tsai, Su Shan ^b   Shih, Tung Sheng ^c,d   Lin, Ming Hsiu ^c   Chou, Tzu Chieh ^d   Ting, Hua ^e,f   Wu, Trong Neng ^a,g   Liou, Saou Hsing ^a,b,d  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c Ministry of Economic Affairs   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

Apnea hypopnea; High sensitivity C reactive protein; Metabolic syndrome; Obstructive sleep apnea

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; TRIACYLGLYCEROL;

ADULT; AMINO ACID BLOOD LEVEL; APNEA HYPOPNEA INDEX; ARTICLE; BLOOD BIOCHEMISTRY; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRINKING BEHAVIOR; DRIVER; EDUCATIONAL STATUS; EMPLOYMENT STATUS; GLUCOSE BLOOD LEVEL; HEART DISEASE; HUMAN; HYPERTENSION; IMMUNOASSAY ANALYZER; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICAL HISTORY; METABOLIC SYNDROME X; MIDDLE AGED; OXYGEN DESATURATION; POLYSOMNOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULSE OXIMETER; SLEEP DISORDERED BREATHING; SMOKING; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; CLASSIFICATION; COHORT ANALYSIS; IMMUNOLOGY; METABOLISM; SENSITIVITY AND SPECIFICITY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS;

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; COHORT STUDIES; HUMANS; MALE; METABOLIC SYNDROME X; POLYSOMNOGRAPHY; SENSITIVITY AND SPECIFICITY; SLEEP APNEA, OBSTRUCTIVE; STATISTICS AS TOPIC; TAIWAN;

EID: 84949100492     PISSN: 15209512     EISSN: 15221709     Source Type: Journal    
DOI: 10.1007/s11325-015-1166-2     Document Type: Article

References (32)

1. Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136–143
2. Lindberg E, Gislason T (2000) Epidemiology of sleep-related obstructive breathing. Sleep Med Rev 4:411–433
3. Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217–1239
4. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378–1384
5. Nieto FJ, Young TB, Lind BK et al (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep heart health study. JAMA 283:1829–1836
6. Ip MS, Lam B, Ng MM, Lam WK et al (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676
7. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677–682
8. Kiely JL, McNicholas WT (2000) Cardiovascular risk factors in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:128–133
9. Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin, and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839
10. Kohler M, Stradling JR (2010) Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol 7:677–685
11. Garvey JF, Taylor CT, McNicholas WT (2009) Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. Eur Respir J 33:1195–1205
12. Ohga E, Tomita T, Wada H, Yamamoto H, Nagase T, Ouchi Y (2003) Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol 94:179–184
13. Yokoe T, Minoguchi K, Matsuo H et al (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134
14. Shamsuzzaman AS, Winnicki M, Lanfranchi P et al (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464
15. Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E (2007) Correlates of serum C-reactive protein (CRP)–no association with sleep duration or sleep disordered breathing. Sleep 30:991–996
16. Tasali E, Ip MS (2008) Obstructive sleep apnea and metabolic syndrome: alterations in glucose metabolism and inflammation. Proc Am Thorac Soc 5:207–217
17. AASM (2001) The international classification of sleep disorders: diagnostic and coding manual. American Academy of Sleep Medicine, Westchester
18. Ruehland WR, Rochford PD, O’Donoghue FJ, Pierce RJ, Singh P, Thornton AT (2009) The new AASM criteria for scoring hypopneas: impact on the apnea hypopnea index. Sleep 32:150–157
19. Health Promotion Administration, Ministry of Health and Welfare. The Definition of the Metabolic Syndrome in Adults, 2007. Available online: http://www.hpa.gov.tw/BHPNet/Web/HealthTopic/TopicArticle.aspx?No=200712250123&parentid=200712250023 Accessed 01 May 2007
20. Lin YC, Yen LL, Chen SY et al (2003) Prevalence of overweight and obesity and its associated factors: findings from national nutrition and health survey in Taiwan, 1993–1996. Prev Med 37:233–241
21. Pan WH, Flegal KM, Chang HY, Yeh WT, Yeh CJ, Lee WC (2004) Body mass index and obesity-related metabolic disorders in Taiwanese and US whites and blacks: implications for definitions of overweight and obesity for Asians. Am J Clin Nutr 79:31–39
22. Ridker PM, Paynter NP, Rifai N, Gaziano JM, Cook NR (2008) C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds risk score for men. Circulation 118:2243–2251
23. Harris TB, Ferrucci L, Tracy RP et al (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 106:506–512
24. Kanagy NL, Walker BR, Nelin LD (2001) Role of endothelin in intermittent hypoxia-induced hypertension. Hypertension 37:511–515
25. Lesske J, Fletcher EC, Bao G, Unger T (1997) Hypertension caused by chronic intermittent hypoxia–influence of chemoreceptors and sympathetic nervous system. J Hypertens 15:1593–1603
26. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706–712
27. Kohler M, Ayers L, Pepperell JC et al (2009) Effects of continuous positive airway pressure on systemic inflammation in patients with moderate to severe obstructive sleep apnoea: a randomised controlled trial. Thorax 64:67–73
28. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR (2007) Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 62:969–974
29. Minoguchi K, Yokoe T, Tazaki T et al (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630
30. Lui MM, Lam JC, Mak HK et al (2009) C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest 135:950–956
31. Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax 62:509–514
32. IOTF (2000) Asia–Pacific perspective: redefining obesity and its treatment. International Obesity Task Force, Western Pacific Region, Sydney